KeepsvsNutrafol Men

Keeps itself is a telehealth service, not a drug; an online clinician reviews your intake and prescribes generic medications shipped to your door. The actual hair regrowth comes from two well-studied ingredients. Finasteride is an oral Type II 5-alpha-reductase inhibitor that lowers scalp DHT, the hormone that miniaturizes genetically susceptible follicles, thereby slowing loss and allowing some regrowth. Minoxidil is a topical vasodilator thought to prolong the follicle's growth (anagen) phase and increase blood flow to follicles, helping produce thicker hair; its exact mechanism in hair growth is still not fully understood. Keeps also offers a compounded once-daily topical finasteride/minoxidil gel and foam (0.25% finasteride, 5% minoxidil), ketoconazole 2% shampoo, and may offer dutasteride for some patients.

Nutrafol Men is an oral nutraceutical (not a drug) that aims to address several contributors to thinning hair at once rather than acting on a single pathway. Standardized saw palmetto is included to mildly reduce conversion of testosterone to DHT, the hormone that shrinks genetically sensitive follicles; ashwagandha is an adaptogen meant to blunt stress hormones like cortisol; and curcumin, tocotrienols (vitamin E) and other antioxidants target oxidative stress and micro-inflammation around the follicle. Vitamins, minerals, hydrolyzed marine collagen (fish-derived) and amino acids supply building blocks for the hair shaft. The idea is to nudge follicles back toward the active growth (anagen) phase. Note that its DHT-lowering effect from saw palmetto is far weaker and less established than prescription finasteride, and the multi-ingredient design makes it hard to know which components, if any, drive results.

The medications Keeps prescribes have strong evidence; Keeps has not published its own large clinical trials. In a multinational study of men with male pattern hair loss, oral finasteride 1 mg daily produced durable hair-count improvement over five years while placebo users progressively lost hair (p<0.001 for all endpoints; PubMed 11809594). Earlier pivotal trials showed roughly two-thirds of finasteride users had visible improvement versus continued loss on placebo. For minoxidil, a 48-week randomized trial in 393 men found 5% topical minoxidil significantly superior to 2% and placebo in non-vellus hair count, and a separate 16-week foam trial in 352 men showed significant hair-count gains versus placebo (P<.0001). Smaller studies suggest combining finasteride and minoxidil may outperform either alone. Benefits require continuous use; stopping reverses gains within months.

The pivotal evidence is a 6-month, multi-center, randomized, double-blind, placebo-controlled trial in men with thinning hair, published in the Journal of Cosmetic Dermatology (Bhatia et al., 2025; PMC11701407). Of 112 enrolled, 85 completed per protocol (52 active, 33 placebo). Notably, the original objective primary endpoint—change in mean terminal hair count via Canfield HairMetrix—was abandoned because numerous protocol deviations at clinical sites rendered many measurements unusable, so only secondary outcomes are reported. At Day 180, blinded investigators rated hair growth "improved" in 79% of the active group versus 51% on placebo (p<0.01) and hair quality improved in 74% versus 54% (p=0.026). On a self-report questionnaire, 85% versus 55% felt the treatment slowed their hair loss (p<0.05) and 46% versus 24% were satisfied with hair on top (p<0.05). So the trial shows a real, statistically significant edge over placebo, but the surviving outcomes are subjective, the dropout (about 24%) was substantial, and the study was funded by Nutraceutical Wellness Inc. (Nutrafol's maker) with several authors employed by or paid as advisors to the company.

Minoxidil's common side effects are local: scalp itching, dryness, flaking, or irritation, plus possible temporary "shedding" in the first weeks. Unwanted facial or body hair can occur if it spreads beyond the scalp. Finasteride's notable risks are sexual: in Merck's Phase III trials about 1.3-1.8% of men reported decreased libido, erectile dysfunction, or ejaculation problems (versus roughly 0.7-1.3% on placebo), usually reversible after stopping. A debated but reported condition, "post-finasteride syndrome," describes sexual or mood symptoms persisting after discontinuation. The FDA-approved finasteride 1 mg (Propecia) label lists depression and, since an August 2022 update, suicidal ideation and behavior among postmarketing adverse reactions. Finasteride also lowers PSA, and the label notes a possible increased risk of high-grade prostate cancer. Seek medical care for mood changes, persistent sexual dysfunction, breast lumps or tenderness, or signs of an allergic reaction.

Nutrafol Men is generally well tolerated. In the trial, eight possibly or probably related adverse events occurred in six subjects (three in the active group, three on placebo), all gastrointestinal—bloating, stomach irritation, diarrhea, intermittent nausea—with two participants withdrawing for moderate GI upset and no serious adverse events. Outside the trial, users occasionally report mild stomach upset, headache, or unwanted body or facial hair from general follicle stimulation. A key practical caution: the formula's biotin can interfere with lab tests (thyroid, troponin/cardiac, hormone panels), and the FDA has linked biotin interference to falsely low troponin results, including one reported death, so stop biotin-containing supplements before bloodwork (commonly advised at least 72 hours ahead) and tell your provider you take it. Botanical supplements such as saw palmetto and ashwagandha have rare case reports of liver issues; stop and see a doctor if you develop dark urine, jaundice, or upper-right abdominal pain. Dietary supplements are not reviewed by the FDA for safety and efficacy the way prescription drugs are.

As of 2026, Keeps positions itself as budget-friendly: individual plans often start around $10-25 per month (minoxidil at the low end, generic finasteride roughly $17-25), with combination and compounded multi-ingredient formulas costing more, plus a roughly $5 shipping fee per order. Longer 6- or 12-month commitments usually lower the per-month price, and the online consultation is typically free or low-cost. Insurance generally does not cover cosmetic hair-loss treatment. Because these are generics, it's worth comparing: a GoodRx coupon for generic finasteride or minoxidil at a local pharmacy can sometimes match or beat subscription pricing, though you'd manage the prescription and refills yourself. Keeps' parent company agreed to be acquired in late 2025, so verify current prices on the Keeps website before subscribing.

As of 2026, Nutrafol Men typically runs about $88 for a one-time single bottle (one-month supply) and around $79/month on a standard monthly subscription (roughly a 10% saving), with larger discounts—commonly 15-25%—on prepaid 3-month or 6-month plans (a 3-month subscription is around $237, sometimes lower with deeper promotions). It is a dietary supplement, so it is not covered by health insurance and does not qualify for typical pharmacy discount cards; however, many FSA/HSA accounts may reimburse it, and it's sometimes sold through dermatology and med-spa offices. For comparison, generic finasteride and minoxidil—both FDA-approved with stronger regrowth evidence—often cost roughly $10-$30/month (frequently under $30 with pharmacy coupons), making Nutrafol a premium-priced choice. Prices vary by retailer and promotion, so confirm the current price at checkout.

Keeps is designed for adult men (18+) with hereditary male pattern hair loss (androgenetic alopecia), and works best on early-to-moderate thinning at the crown and hairline rather than long-established bald areas. Finasteride is FDA-indicated for men only and is contraindicated in women who are or may become pregnant, who should not handle crushed or broken tablets, because it can cause genital abnormalities in a male fetus. Men with a history of depression or mood disorders, men planning to father children, or those with prostate-cancer concerns should discuss finasteride carefully with a clinician, since it lowers PSA levels (affecting prostate-cancer screening) and its label notes that 5-alpha-reductase inhibitors may increase the risk of high-grade prostate cancer. Men who want to avoid hormonal side effects entirely can use minoxidil alone.

Best suited for adult men (typically 18+) with early-stage, self-perceived thinning or diffuse shedding who want a drug-free, over-the-counter approach and can wait 3-6 months for results. It is a supplement, not a cure for advanced male-pattern baldness. Note that it contains hydrolyzed marine collagen sourced from North Atlantic cod, so anyone with a fish allergy should avoid it (the manufacturer labels the product shellfish-, gluten-, and soy-free). Consult a doctor first if you take blood thinners, have liver disease, take medications affecting hormones, or have a hormone-sensitive condition. Pause biotin-containing supplements about 72 hours before any blood test, as biotin can skew thyroid, cardiac (troponin) and other lab assays. Pregnant or breastfeeding people and anyone under 18 should not use it without medical guidance. Always discuss new supplements with a clinician, especially if you take prescription drugs.